Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objectives: To give an overview of the genetic and structural abnormalities occurring in fetuses with nuchal translucency (NT) measurement exceeding the 95th percentile at first‐trimester screening and to investigate which of these abnormalities would be missed if cell‐free fetal DNA (cfDNA) were used as a first‐tier screening test for chromosomal abnormalities. Methods: This is a national study including 1901 pregnancies with NT≥95th percentile referred to seven university hospitals in the Netherlands between 1 January 2010 and 1 January 2016. All cases with unknown pregnancy outcome were excluded. Results of detailed ultrasound examinations, karyotyping, genotyping, pregnancy and neonatal outcomes, investigation by a clinical geneticist and post‐mortem investigations were collected. Results: In total, 821 (43%) pregnancies had at least one abnormality. The rate of abnormalities was 21% for fetuses with NT between 95 th and 99 th percentile and 62% for fetuses with NT≥99 th percentile. Prevalence of single‐gene disorders, submicroscopic, chromosomal and structural abnormalities was 2%, 2%, 30% and 9%, respectively. Conclusion: Although cfDNA is superior to the combined test, especially for the detection of trisomy 21, 34% of the congenital abnormalities occurring in fetuses with increased NT may remain undetected in the first trimester of pregnancy, unless cfDNA is used in combination with fetal sonographic assessment, including NT measurement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Snijders, R., Noble, P., Sebire, N., Souka, A., & Nicolaides, K. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11280-6 · Cited by 1,572 · cited 1×
“5mm, corresponding to the 99 centile.(40) Our results support that this cut‐off has the highest sensitivity and specificity to detect congenital abnormalities.”
BackgroundKarim, J. N., Roberts, N. W., Salomon, L. J., & Papageorghiou, A. T. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17246 · Cited by 266
Relation between increased fetal nuchal translucency thickness and chromosomal defects
Kagan, K. O., Avgidou, K., Molina, F. S., Gajewska, K., & Nicolaides, K. H. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000191301.63871.c6 · Cited by 171
Chitty, L. S., Wright, D., Hill, M., Verhoef, T. I., Daley, R., Lewis, C., Mason, S., McKay, F., Jenkins, L., Howarth, A., et al. (2016) · BMJ · doi:10.1136/bmj.i3426 · Cited by 149
Cut-off value of nuchal translucency as indication for chromosomal microarray analysis
Maya, I., Yacobson, S., Kahana, S., Yeshaya, J., Tenne, T., Agmon‐Fishman, I., Cohen‐Vig, L., Shohat, M., Basel‐Vanagaite, L., & Sharony, R. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17421 · Cited by 65
van Schendel, R. V., Page‐Christiaens, G. C. M. L., Beulen, L., Bilardo, C. M., de Boer, M. A., Coumans, A. B. C., Faas, B. H. W., van Langen, I. M., Lichtenbelt, K. D., van Maarle, M. C., et al. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0118-3 · Cited by 59
Self-citationImplications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies
Grati, F. R., Bajaj, K., Zanatta, V., Malvestiti, F., Malvestiti, B., Marcato, L., Grimi, B., Maggi, F., Simoni, G., Gross, S. J., et al. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5138 · Cited by 50 · cited 1×
“This also negatively affects the positive predictive value of the screening test, which inevitably decreases.(12,26,27) The net result is that genome‐wide cfDNA undermines the main advantage of this screening test above the CT, which is to reduce the need for invasive testing.”
Background
Cited by
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Hui, L., Ellis, K., Mayen, D., Pertile, M. D., Reimers, R., Sun, L., Vermeesch, J., Vora, N. L., & Chitty, L. S. (2023) · Prenatal Diagnosis · doi:10.1002/pd.6357 · Cited by 109
Buijtendijk, M. F., Bet, B. B., Leeflang, M. M., Shah, H., Reuvekamp, T., Goring, T., Docter, D., Timmerman, M. G., Dawood, Y., Lugthart, M. A., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014715.pub2 · Cited by 47
Self-citation
Metadata
- Authors
- Bardi, F., Bosschieter, P., Verheij, J., Go, A., Haak, M., Bekker, M., Sikkel, E., Coumans, A., Pajkrt, E., & Bilardo, C.
- Venue
- Prenatal Diagnosis
- Publisher
- Wiley
- Published
- 2019-11-27
- Volume
- 40
- Issue
- 2
- Pages
- 197-205
- ISSN
- 0197-3851 (ISSN-L)
- 1097-0223
- OpenAlex
- W2988420331
- Cited by
- 89
- References
- 7
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening? https://app.cochat.ai/papers/10.1002/pd.5590
- The paper
- Bardi, F., Bosschieter, P., Verheij, J., Go, A., Haak, M., Bekker, M., Sikkel, E., Coumans, A., Pajkrt, E., & Bilardo, C. (2020). Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening? Prenatal Diagnosis. https://doi.org/10.1002/pd.5590
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.